Femasys (FEMY) Research & Development (2020 - 2025)
Femasys posted quarterly Research & Development of $1.4 million for Q2 2025, up 112.53% year-on-year from $665517.0 in Q2 2024, and down 52.35% on a QoQ basis from $3.0 million in Q1 2025.
Femasys (FEMY) has 6 years of Research & Development data on file, last reported at $1.4 million in Q2 2025.
- For the quarter ending Q2 2025, Research & Development rose 112.53% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2025 stood at $8.9 million (up 34.53% YoY), and the FY2025 full-year result was $7.6 million, down 7.78% from the prior year.
- Research & Development for Q2 2025 stood at $1.4 million, down from $3.0 million in the prior quarter.
- Across five years, Research & Development topped out at $3.0 million in Q1 2025 and bottomed at $665517.0 in Q2 2024.
- The 5-year median for Research & Development is $1.5 million (2022), against an average of $1.6 million.
- The widest annual swing landed in 2024, when Research & Development tumbled 56.42%; it then surged 112.53% in 2025.
- A 5-year view of Research & Development shows it stood at $1.1 million in 2021, then grew by 20.66% to $1.3 million in 2022, then jumped by 62.89% to $2.1 million in 2023, then climbed by 4.61% to $2.2 million in 2024, then tumbled by 34.72% to $1.4 million in 2025.
- The last three Research & Development figures came in at $1.4 million (Q2 2025), $3.0 million (Q1 2025), and $2.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 94.27 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 15.80 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 189.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 44.30 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 98.66 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 139.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Femasys | 22.30 Mn | 16.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 665,517.00 |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 2.07 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 1.42 Mn |
| Dec 31, 2021 | 1.05 Mn |
| Sep 30, 2021 | 1.14 Mn |
| Jun 30, 2021 | 894,868.00 |
| Mar 31, 2021 | 995,022.00 |
| Dec 31, 2020 | 895,591.00 |
| Sep 30, 2020 | 995,620.00 |
| Jun 30, 2020 | 888,701.00 |